Related Experiment Video
Updated: Feb 5, 2026

RNA Interference in Ticks
Published on: January 20, 2011
RNA interference to enhance radiation therapy: Targeting the DNA damage response
G Ratnayake1, A L Bain2, N Fletcher3
1Centre of Advanced Imaging, University of Queensland, Australia; Australian Institute of Bioengineering and Nanotechnology, University of Queensland, Australia; QIMR Berghofer Medical Research Institute, Australia; Royal Brisbane and Women's Hospital, Australia.
Abstract:
RNA interference (RNAi) therapy is an emerging class of biopharmaceutical that has immense potential in cancer medicine. RNAi medicines are based on synthetic oligonucleotides that can suppress a target protein in tumour cells with high specificity. This review explores the attractive prospect of using RNAi as a radiosensitiser by targeting the DNA damage response. There are a multitude of molecular targets involved in the detection and repair of DNA damage that are suitable for this purpose. Recent developments in delivery technologies such nanoparticle carriers and conjugation strategies have allowed RNAi therapeutics to enter clinical trials in the treatment of cancer. With further progress, RNAi targeting of the DNA damage response may hold great promise in guiding radiation oncology into the era of precision medicine.
Insights
RNA interference (RNAi) therapy shows promise as a cancer radiosensitizer by targeting DNA damage repair. Advances in delivery systems are enabling RNAi therapeutics for clinical cancer treatment, advancing precision medicine.
Area of Science:
- Biopharmaceutical development
- Molecular oncology
- Radiosensitization strategies
Background:
- RNA interference (RNAi) therapy utilizes synthetic oligonucleotides to specifically suppress target proteins in tumor cells.
- RNAi therapeutics represent an emerging biopharmaceutical class with significant potential in cancer medicine.
Purpose of the Study:
- To explore the potential of RNA interference (RNAi) as a radiosensitizer in cancer treatment.
- To investigate targeting the DNA damage response pathway for enhanced radiation therapy efficacy.
Main Methods:
- Review of current literature on RNAi mechanisms and DNA damage response pathways.
- Analysis of recent advancements in RNAi delivery technologies, including nanoparticle carriers and conjugation strategies.
- Examination of clinical trial progress for RNAi therapeutics in cancer treatment.
Main Results:
- Multiple molecular targets within the DNA damage detection and repair pathways are suitable for RNAi-based radiosensitization.
- Delivery technologies have advanced, enabling RNAi therapeutics to enter clinical trials for cancer.
- RNAi targeting of DNA damage response presents a promising strategy for enhancing radiation oncology.
Conclusions:
- RNAi therapy holds significant potential for cancer medicine, particularly as a radiosensitizer.
- Targeting the DNA damage response with RNAi could revolutionize radiation oncology.
- Further development of RNAi delivery and targeting strategies is crucial for realizing precision medicine in cancer care.
Related Concept Videos
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Interference and Diffraction
Biological Effects of Radiation
RNA Polymerase II Accessory Proteins
DNA Damage Can Stall the Cell Cycle

